TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
PharmaLex Sweden AB
Closing information (x1000 EUR)
| Closing information | 2023/09 | 2022/12 | 2021/12 |
| Turnover |
2,413
|
2,406
|
1,697 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
36
|
243
|
117 |
| EBITDA |
36
|
245
|
119 |
| Total assets |
864
|
835
|
694 |
| Current assets |
861
|
830
|
688 |
| Current liabilities |
636
|
491
|
529 |
| Equity capital |
229
|
344
|
165 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
12
|
11
|
9 |
Financial ratios
| Fiscal year | 2023/09 | 2022/12 | 2021/12 |
| Solvency |
26.5%
|
41.2%
|
23.8% |
| Turnover per employee |
201
|
219
|
189 |
| Profit as a percentage of turnover |
1.5%
|
10.1%
|
6.9% |
| Return on assets (ROA) |
4.2%
|
29.1%
|
16.9% |
| Current ratio |
135.4%
|
169.0%
|
130.1% |
| Return on equity (ROE) |
15.7%
|
70.6%
|
70.9% |
| Change turnover |
83
|
847
|
336 |
| Change turnover % |
4%
|
54%
|
25% |
| Chg. No. of employees |
1
|
2
|
1 |
| Chg. No. of employees % |
9%
|
22%
|
13% |
Total value of public sale
| Fiscal year | 2023/09 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.